Acrotech Biopharma INC.
At a glance
Employees20-99
In business sinceNot reported
HeadquartersEast Windsor, NJ
US patents4
SAM.gov UEIDN63NKTYLF33
CAGE code8AH83
Incorporated inNJ
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2022–2024, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereofUS 12,016,830 · granted JUN 25, 2024
- Ready-to-use formulation for Vincristine Sulfate Liposome InjectionUS 11,559,486 · granted JAN 24, 2023
- Compositions comprising disodium levofolinateUS 11,541,012 · granted JAN 3, 2023
- Combination therapy using belinostat and pralatrexate to treat lymphomaUS 11,439,643 · granted SEP 13, 2022
Granted to Acrotech Biopharma, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Acrotech Biopharma INC. | East Windsor | NJ | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.